Dr Suresh Jadhav, ED, SII passes away
08 December 2021 | News
The pioneer for Covishield vaccine was 72
Image credit: linkedin.com
Dr Suresh Jadhav, Executive Director, Serum Institute of India (SII) recently passed away at the age of 72 in Pune.
Dr Jadhav was instrumental in the development of the CoviShield vaccine for COVID-19 from SII.
Dr Jadhav led the project of development and introduction of Meningococcal A Conjugate Vaccine in Sub-Saharan African belt, the development of Seasonal & Pandemic Influenza Vaccines and also played major role in acquisition of Bilthoven Biologicals, a Netherlands based Govt. Vaccine manufacturing company.
He was associated with Developing Countries Vaccine Manufacturers’ Network (DCVMN) since its inception in 2000 and was the President of DCVMN from 2003 till 2008.
